Technical Analysis for ANRO - Alto Neuroscience, Inc.
ADX | Long Term | Intermediate Term | Short Term |
---|---|---|---|
Weak or Absent | N/A | Down | Down |
Date | Alert Name | Type | % Chg |
---|---|---|---|
Pocket Pivot | Bullish Swing Setup | 0.00% | |
Volume Surge | Other | 0.00% | |
Up 3 Days in a Row | Strength | 0.00% | |
Slingshot Bearish | Bearish Swing Setup | 0.56% | |
Stochastic Buy Signal | Bullish | 0.56% | |
Lower Bollinger Band Walk | Weakness | 0.56% | |
Oversold Stochastic | Weakness | 0.56% | |
Lower Bollinger Band Walk | Weakness | 7.33% | |
New 52 Week Low | Weakness | 7.33% | |
Multiple of Ten Bearish | Other | 7.33% |
Alert | Time |
---|---|
2x Volume Pace | 1 day ago |
1.5x Volume Pace | 1 day ago |
3x Volume Pace | 1 day ago |
10x Volume Pace | 1 day ago |
5x Volume Pace | 1 day ago |
Get this analysis on your stocks daily!
Let us help you stay on top of your investments. We will alert you to important technical developments on your
portfolio & watchlist.
Configure default chart indicators
Basic chart:
- Earnings date: 03/21/2024
Alto Neuroscience is a clinical-stage biopharmaceutical company with a mission to redefine psychiatry by leveraging neurobiology to develop personalized and highly effective treatment options. Alto's Precision Psychiatry Platform™ measures brain biomarkers by analyzing EEG activity, neurocognitive assessments, wearable data, and other factors to better identify which patients are more likely to respond to Alto product candidates. Alto’s clinical-stage pipeline includes novel drug candidates in depression, PTSD, schizophrenia, and other mental health conditions.
Sector: Healthcare
Industry: Biotechnology
Keywords: Biopharmaceutical Neuroscience Schizophrenia Biomarkers Depression Neurophysiology Post Traumatic Stress Disorder Electroencephalography Neurocognition Ptsd
Classification
Sector: Healthcare
Industry: Biotechnology
Keywords: Biopharmaceutical Neuroscience Schizophrenia Biomarkers Depression Neurophysiology Post Traumatic Stress Disorder Electroencephalography Neurocognition Ptsd
Indicator | Bull Case | Neutral / Hold | Bear Case |
---|---|---|---|
50 DMA | |||
200 DMA | |||
ADX Trend | |||
Oversold / Overbought | |||
Relative Strength |
Indicator | Value |
---|---|
52 Week High | 24.0 |
52 Week Low | 9.4 |
Average Volume | 117,234 |
200-Day Moving Average | 0.00 |
50-Day Moving Average | 12.72 |
20-Day Moving Average | 11.30 |
10-Day Moving Average | 10.79 |
Average True Range | 0.80 |
RSI (14) | 40.48 |
ADX | 19.8 |
+DI | 17.14 |
-DI | 24.42 |
Chandelier Exit (Long, 3 ATRs) | 10.39 |
Chandelier Exit (Short, 3 ATRs) | 11.79 |
Upper Bollinger Bands | 12.76 |
Lower Bollinger Band | 9.85 |
Percent B (%b) | 0.29 |
BandWidth | 25.77 |
MACD Line | -0.66 |
MACD Signal Line | -0.62 |
MACD Histogram | -0.0373 |
Pivot Point Level | Traditional / Classic | Fibonacci | Demark | Woodie | Camarilla |
---|---|---|---|---|---|
Resistance 4 (R4) | 11.89 | ||||
Resistance 3 (R3) | 11.85 | 11.41 | 11.69 | ||
Resistance 2 (R2) | 11.41 | 11.10 | 11.43 | 11.62 | |
Resistance 1 (R1) | 11.05 | 10.92 | 11.23 | 11.09 | 11.56 |
Pivot Point | 10.61 | 10.61 | 10.70 | 10.63 | 10.61 |
Support 1 (S1) | 10.25 | 10.30 | 10.43 | 10.29 | 9.82 |
Support 2 (S2) | 9.81 | 10.12 | 9.83 | 9.76 | |
Support 3 (S3) | 9.45 | 9.81 | 9.69 | ||
Support 4 (S4) | 9.49 |